Personality
6
Open
6
Cons
5
Extr
5
Agre
4
Neur
Lupin
Healthcare · Mega Cap
Mature Stable · Hierarchical
About
Nilesh Gupta is the Managing Director of Lupin, a Mega Cap company in the Healthcare sector with a market cap of ₹105K Cr. A Pragmatic leader with 23 years of experience, he is known for authority-driven decision-making and aggressive acquirer strategy. Directs management efforts toward stabilizing regulatory compliance and streamlining operations after periods of aggressive geographic expansion.
FAQ
What is Nilesh Gupta's leadership style?
Nilesh Gupta is classified as a Pragmatic leader. He is authority-driven in decision-making, with a dynasty builder motivation and steady-marathon pace of execution.
What is Nilesh Gupta's educational background?
Nilesh Gupta holds a B.Tech Chemical Engineering from UDCT Mumbai (now ICT Mumbai) and a MBA from Wharton School, University of Pennsylvania.
Who is the CEO of Lupin?
Nilesh Gupta is the Managing Director of Lupin. He has been with the company for 23 years and in the current role for 12 years.
Leadership DNA
ArchetypePragmatic
MotivationDynasty Builder
CrisisRestructurer
DecisionAuthority-Driven
GrowthAggressive Acquirer
PeopleRelationship Led
InnovationFast-Follower
PaceSteady-Marathon
PurposePurpose-Blended
CustomerB2B-Enterprise
EmployerLearning Ground
BrandTrusted
FocusOperational Excellence
OrientationDeep Specialist
Leadership Evidence
“Directs management efforts toward stabilizing regulatory compliance and streamlining operations after periods of aggressive geographic expansion.”
⚡ Crisis●●●●○
Gupta has consistently reshaped Lupin's portfolio by divesting non-core assets and focusing on complex generics and specialty niches to navigate regulatory and pricing pressures.
🎯 Motivation●●●●●
As part of the founding Deshbandhu Gupta family, his leadership is defined by long-term stewardship and the transition of the business to the next generation of the family.
👥 People●●●○○
Lupin maintains a culture characterized by long-tenured employees and deep loyalty to the founding family's values, reflecting a traditional promoter-led management style.
📈 Growth●●●●○
Gupta has driven growth through significant international acquisitions, such as the Gavis Pharmaceuticals deal, to expand Lupin's footprint in the US specialty market.
💡 Innovation●●●●○
Lupin excels at reverse-engineering complex generics and building scale in regulated markets like the US after initial patent expiries.
🏃 Pace●●●●○
As a legacy pharmaceutical player, the company operates on long-cycle R&D and regulatory approval timelines that prioritize consistency over rapid pivots.
🌱 Purpose●●●●○
The Lupin Foundation focuses extensively on rural development and healthcare access, integrating these initiatives into their broader ESG reporting framework.
🏷️ Brand●●●●○
With a decades-long history in the pharmaceutical space, Lupin maintains a reputation for reliability and quality compliance among doctors and healthcare institutions.
🤝 Customer●●●●○
The bulk of Lupin's revenue is driven by business-to-business sales to distributors, hospital chains, and pharmacy benefit managers globally.
💼 Employer●●●○○
Lupin is widely regarded in the Indian pharma industry as a strong training ground for technical and regulatory expertise, with many employees moving to other firms after gaining experience.
📋 Mandate
Recovery efforts necessitate a streamlined cost structure and improved manufacturing compliance to navigate complex global regulatory requirements.
🏢 Culture●●●●○
Long-standing family-promoted pharmaceutical business with a structured, traditional management hierarchy.
Financials
Revenue FY25₹22K Cr
PAT FY25₹3K Cr
Rev CAGR 5Y11.1%
OPM19.6%
NPM14.8%
ROE19.1%
ROCE21.5%
P/E22.8
Fwd P/E23.7
P/B5.4
D/E31.5
Promoter47%
Institutional32.9%
Mkt Cap₹105K Cr
Compensation
To Be Published
Data being verified from audited reports
